Methocarbamol
Back to searchMolecule Structure
Scientific Name
Methocarbamol
Description of the Drug
Methocarbamol is a CNS depressant indicated with rest, physical therapy and other treatments to control the discomfort associated with various acute musculoskeletal conditions.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00423
http://www.drugbank.ca/drugs/DB00423
Brand Name(s)
Delaxin, Forbaxin, Methocarbamol, Miolaxin, Neuraxin, Robaxin, Robaxin-750
Company Owner(s)
Sun Pharmaceutical Industries Inc, Mlv Pharma Llc, Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc, Kv Pharmaceutical Co, Watson Laboratories Inc, American Regent Inc, Auxilium Pharmaceuticals Llc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co, Jerome Stevens Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Carbonic anhydrase I | SINGLE PROTEIN | INHIBITOR | CHEMBL261 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34365 | |
| PharmGKB | PA164749506 | |
| Human Metabolome Database | HMDB0014567 | |
| DrugBank | DB00423 | |
| PubChem: Thomson Pharma | 15220927 | |
| PubChem | 4107 | |
| Mcule | MCULE-7298838587 | |
| LINCS | LSM-1453 | |
| Nikkaji | J2.065F | |
| BindingDB | 50239995 | |
| EPA CompTox Dashboard | DTXSID6023286 | |
| DrugCentral | 1747 | |
| ChemicalBook | CB3148129 | |
| Guide to Pharmacology | 6829 | |
| rxnorm | METHOCARBAMOL | ROBAXIN |
| ChEBI | 77498 |
